Артериальная гипертензия

Расширенный поиск

30-летний юбилей нифедипина. Новые исследования открывают новые возможности

Полный текст:

Об авторе

А. О. Конради
НИИ кардиологии им. В.А.Алмазова М3 и СР РФ

Список литературы

1. Mac Mahon N.B., Саитап S. Effects of АСЕ inhibitors, calcium antagonists, and other blood pressure lowering drugs results of prospectively designed overviews of randomized trials BPLTCT Lancet 2004, 345 1076-78

2. Brown M., Palmer C., Castaigne L. et al. Morbidity and Mortality in Patients Randomized to Double-Blind Treatment with Long-Acting Calcium Channel Blockers or Diuretic m the International Nifedipine GITS Study Intervention as a Goal in Hypertensive Treatment (INSIGHT) Lancet 2000, 356 366-72

3. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic The Antihypertensive and Lipid lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 2002, 288, 2981-79

4. Guidelines Committee 2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension J Hypertension 2003, 21 1011 -53

5. Joint National Committee 2003 report of the Report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC VII) JAMA 2003, 255-61

6. World Health Organization (WHO)/international Society of Hypertension (ISH) statement on management of hypertension J Hypertension 2003, 21 1983-92

7. Agabiti-Rosei E., Zulli R., Muiesan M. et al. Reduction of cardiovascular structural changes by nifedipine GITS m essential hypertensive patients Blood Pressur 1998, 7(3) 160-9

8. Pitt B., Byington R.P., Rurberg C.D. et al. Effect of amlodipme on the progression of atherosclerosis and the occurrence of clinical events PREVENT investigators Circulation 2000, 102 1503-10

9. Motro M., Shemesh J. Calcium channel blocker slows the progression of early coronary calcification m hypertensive patients compared with diuretics Hypertension 2001, 37 1410-1403

10. Simon A., Ganepy J., Moyse D. et al. Different effects ofnifedipme and co-amilozide on the progression of early carotid wall changes Circulation 2001, 103 2949-54

11. Virdis A., Taddei S. et al. Nifedipine improves endothelium dependent vasodilatation by restoring nutric oxide Am J Hypertens 1999, 12 (Suppl) 57A

12. Hempel A., Lindschau C., Maasch C., et al. Calcium antagonists ameliorate ischemia-induced endothelial cell permeability by inhibiting protein kinase С Circulation 1999,99 2523-2529

13. Ghiadom L., Magagna A., Versan D. et al. Different effect of antihypertensive drugs on conduit artery endothelial function Hypertension 2003,41 1281-1286

14. Verhaar M.C., Honing M.L., van Dam T et al. Nifedipine improves endothelial function m hypercholesterolemia, independently of an effect on blood pressure or plasma lipids Cardiovasc Res 1999, 42 752-60

15. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circ Res 2001,89 El-7

16. The ENCORE investigators Effect of nifedipine and cenvastatmeon coronary endothelial function in patients with coronary artery disease, Circulation 203, 107 422-8

17. Poole-Wuilson P.A., Lublen J., Kirwan B.A. et al. Coronary disease trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators Effect of long-term nifedipine on mortality and cardiovascular morbidity m patients with stable angina requiring treatment (ACTION trial) randomized controlled trail Lancet 2004, 364 849-57

18. Lubsen J., Wagener G., Kirwan B.A. et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stale angina and hypertension the ACTION trial J Hypertens 2005 (in press)


Для цитирования:

Конради А.О. 30-летний юбилей нифедипина. Новые исследования открывают новые возможности. Артериальная гипертензия. 2005;11(1):59-62.

Просмотров: 343

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)